Literature DB >> 3878719

Incremental propofol for short procedures.

N Redfern, M A Stafford, C J Hull.   

Abstract

Propofol was used to induce and maintain anaesthesia in patients undergoing minor gynaecological procedures. Quality of anaesthesia, the rate of recovery and the influence of different methods of premedication were assessed. Unpremedicated patients required a higher induction dose than those premedicated with either lorazepam or papaveretum and hyoscine, but maintenance dose requirements were comparable. Regardless of premedication, there were similar decreases in mean arterial pressure, although respiratory function recovered more rapidly in patients premedicated with lorazepam. No significant changes in heart rate were noted in any group. The overall incidence of pain on injection was 3.7% (lignocaine 0.5 mg added to each 9.5 mg of propofol) and a skin rash occurred in 6% of patients. All patients recovered rapidly and uneventfully.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878719     DOI: 10.1093/bja/57.12.1178

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  Comparative evaluation of propofol and thiopentone for total intravenous anaesthesia.

Authors:  H Kashtan; G Edelist; J Mallon; D Kapala
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

2.  Recurrent unilateral lung ventilation disorder in a patient that experienced rocuronium-induced anaphylactic bronchospasm during laparoscopic rectal surgery -A case report-.

Authors:  Won Joon Choi; Soo Il Choi; Jeong Min Mok; Hyun Soo Kim; Yun Hong Kim
Journal:  Korean J Anesthesiol       Date:  2010-10-21

Review 3.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

4.  A comparison of propofol and thiopentone as induction agents in outpatient surgery.

Authors:  G Edelist
Journal:  Can J Anaesth       Date:  1987-03       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.